Normal view MARC view ISBD view

Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection. [electronic resource]

By:

Soleimanzadeh, G

Contributor(s):

Producer: 19940323Description: 759-62 p. digitalISSN:

0042-9686

Subject(s): In: Bulletin of the World Health Organization vol. 71

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

3221 [Clinical study on "sini" decoction on treating stenocardia for coronary heart disease].
by Liang, Yingming
3222 Primary care physicians' attitudes regarding race-based therapies.
by Frank, Danielle
3223 Usefulness of rat skin as a substitute for human skin in the in vitro skin permeation study.
by Takeuchi, Hiroyuki
3224 The "natural" history of severe angina pectoris with intensive medical therapy alone: a five year prospective study of 133 patients.
by Russek, H I
3225 [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
by Müller, G
3226 Flow-mediated vasodilation during pacing of the free epigastric artery bypass graft early and late postoperatively.
by Gurné, O
3227 The role of metabolites in bioequivalency assessment. III. Highly variable drugs with linear kinetics and first-pass effect.
by Jackson, A J
3228 BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
by Bibbins-Domingo, Kirsten
3229 The nitric oxide donor LA 419 decreases ischemic brain damage.
by Serrano, Julia
3230 Specificity of vascular reactivity and remodeling after repeated endothelial injury in a swine model.
by Ohwada, Takayuki
3231 LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders.
by Megson, Ian L
3232 Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence.
by Kumar, Ashish
3233 In vitro dissolution and in vivo bioequivalence evaluation of two brands of isosorbide 5-mononitrate sustained release tablets.
by Kim, Y-H
3234 Synergistic apoptosis-inducing effect of aspirin and isosorbide mononitrate on human colon cancer cells.
by Wang, Xiaodong
3235 Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
by Bai, Ming
3236 Oxygen therapy and vasodilator therapy in patients with chronic lung disease: the effects of episodic pulmonary hypertension during sleep and exercise performance.
by Sawada, M
3237 [Randomized ergometric study of vasodilators combined with betablockaders].
by Witchitz, S
3238 [Acute and long term action of isosorbide dinitrate on the pulmonary circulation, right ventricular function and arterial blood gases in patient with chronic cor pulmonale].
by Schüren, K P
3239 Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris.
by Wallén, N H
3240 Exogenous nitric oxide inhibits platelet activation in whole blood.
by Yoshimoto, H